SRPT PE ratio history
How has SRPT's PE ratio performed in the past
Today
22.04
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A
Sarepta Therapeutics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 49.23 | N/A | $121.59 | $2.47 |
| 2023 | N/A | N/A | $96.43 | -$5.8 |
| 2022 | N/A | N/A | $129.58 | -$8.03 |
| 2021 | N/A | N/A | $90.05 | -$5.15 |
| 2020 | N/A | N/A | $170.49 | -$7.11 |
| 2019 | N/A | N/A | $129.04 | -$9.71 |
| 2018 | N/A | N/A | $109.13 | -$5.46 |
SRPT average PE ratio chart
What is the average PE ratio of SRPT for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A
SRPT PE vs peers
What is SRPT's PE ratio compared to its peers
Compared to its peer stock GILD, SRPT's PE ratio stands lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| SRPT Sarepta Therapeutics Inc | 22.04 | $5.28B |
| GILD Gilead Sciences Inc | 282.24 | $133.56B |
| NVAX Novavax Inc | N/A | $1B |
| PTCT Ptc Therapeutics Inc | N/A | $3.41B |
| BCRX Biocryst Pharmaceuticals Inc | N/A | $1.43B |
| ALNY Alnylam Pharmaceuticals Inc | N/A | $30.52B |
| RNA Avidity Biosciences Inc | N/A | $3.19B |
| INSM INSMED Inc | N/A | $12.52B |
Frequently asked questions
What is Sarepta Therapeutics's PE ratio?
The price to earnings ratio for SRPT stock is 22.04 as of Apr 4, 2025.
How is SRPT's PE ratio calculated (Sarepta Therapeutics PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 4, 2025), Sarepta Therapeutics's stock price is $54.43. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.47. Therefore, Sarepta Therapeutics's P/E ratio for today is 22.04. PE RATIO(22.04) = STOCK PRICE($54.43) / TTM EPS($2.47)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.